| Net income | 74.15M |
| Depreciation | 42.68M |
| Amortization of intangible assets | 8.09M |
| Non-cash interest expense | |
| Amortization of debt issuance costs | 339K |
| Amortization of deferred revenues | |
| (Gain) loss on sale of property and equipment | -1.09M |
| Non-cash loss on early extinguishment of debt | |
| Foreign currency (gain) loss | -104K |
| Provision for (recovery of) doubtful accounts | 351K |
| Deferred income tax (benefit) provision | -17.1M |
| Non-cash stock-based compensation | 9.75M |
| Tax impact of stock-based equity awards | -549K |
| Accounts and notes receivable | |
| Costs and estimated earnings in excess of billings on uncompleted contracts | |
| Inventories | |
| Prepaid expenses and other current assets | |
| Accounts payable and accrued expenses and other non-current liabilities | |
| Billings in excess of costs and estimated earnings on uncompleted contracts | |
| Other, net | |
| Net cash provided by operating activities | |
| Proceeds from sale of property and equipment | 6.85M |
| Additions of property and equipment | -35.87M |
| Payment to acquire equity method investments | |
| Net cash used in investing activities | |
| Proceeds from other long-term debt | |
| Payments on other long-term debt | -860K |
| Payments on convertible notes | |
| Distributions to noncontrolling interest | |
| Tax impact of stock-based equity awards | 549K |
| Exercise of stock options | 146K |
| Repurchase of common stock | 0 |
| Net cash used in financing activities | |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1.11M |
| Net decrease in cash and cash equivalents | -44.98M |
| Cash and cash equivalents, beginning of period | 162.34M |
| Cash and cash equivalents, end of period | 117.37M |
| Interest paid | |
| Redemption premium on convertible subordinated notes | |
| Income taxes paid | |
| Income tax refunds | |